The Conversation published an op-ed about payments made by opioid manufacturers to patient advocacy groups and professional societies.
The writers were Itai Bavli, a PhD candidate in Interdisciplinary Graduate Studies at UBC, and Joel Lexchin of York University.
The piece also appeared in the National Post.
